04.15.25 -- 4 Key Solid Tumor Therapy Objectives iPSCs Can Help Achieve

It's important to evaluate your starting point when scaling an upstream process. Review key considerations for deciding between adherent and suspension cells.

Learn more about this cost-effective, efficient alternative to traditional Protein A resin chromatography for mAb production, enhancing productivity and reducing costs.

Struggling with reproducible cell culture results? Sera variability is a major culprit. Learn how to choose the right sera, test lots, and stock up to ensure consistency and boost reproducibility.

Perfusion cell culture technology supports high cell densities and product yields for viral vaccine manufacturing, offering a reliable way to produce high-quality cells at a commercial scale.

A serum replacement for promoting T cell growth and functionality in cell therapy development shows comparable or superior performance to traditional human serum supplements.

Discover how a vendor-independent partner assists global life science companies and CDMOs with innovative single-use technologies to mitigate risks and ensure uninterrupted manufacturing.

Explore an overview of how mass photometry works and the effort being put in to establish an analytical workflow for gene therapy products.

Can supply chain assurance be maintained while offering an array of possibilities to achieve complex process designs?